Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.15) by 5.22 percent. This is a 0.83 percent decrease over losses of $(1.20) per share from the same period last year. The company reported quarterly sales of $23.57 million which beat the analyst consensus estimate of $22.00 million by 7.15 percent. This is a 232.48 percent increase over sales of $7.09 million the same period last year.
Deciphera Pharmaceuticals Q2 EPS $(1.21) Misses $(1.15) Estimate, Sales $23.57M Beat $22.00M Estimate
Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.15) by 5.22 percent. This is a 0.83 percent decrease over losses of $(1.20) per